Skip to main content
. 2021 Oct 13;12:724277. doi: 10.3389/fimmu.2021.724277

Figure 5.

Figure 5

Connections between biological AD risk genes and drugs that were approved for other indications. Representative connections between AD biological genes (green); genes in PPIs (yellow); target drugs (blue); indication (orange). Grey lines indicate connections. Only IL1R1, BIRC5, B2M, and AURKB are directly connected to a biological gene-drug (anakinra, reserpine, berberine, copper, hesperidin); all other biological gene-drug connections are through the PPI network.